logo
Letter to the editor
Letter to the editor
Letter to the Editor
Letter to the Editor
Evidence-Based Infection Control In Clinical Practice: If You Buy Clothes for the Emperor, Will He Wear Them?
NOD2 mRNA Expression and NFkappaB Activation in Dogs with Lymphocytic Plasmacytic Colitis
Phylogenetic Analysis of Feline Coronavirus Strains in an Epizootic Outbreak of Feline Infectious Peritonitis
Gastrointestinal Hemodynamics in Dogs with Nonfood Induced Atopic Dermatitis
Effect of Endoscopic Forceps on Quality of Duodenal Mucosal Biopsy in Healthy Dogs
Hypercoagulability in Dogs with Protein-Losing Nephropathy as Assessed by Thromboelastography
Comparison of 2 Retrieval Devices for Heartworm Removal in 52 Dogs with Heavy Worm Burden
Feline Musculoskeletal Pain Index: Responsiveness and Testing of Criterion Validity
Prospective Evaluation of Biweekly Streptozotocin in 19 Dogs with Insulinoma
Acquired Proximal Renal Tubular Dysfunction in 9 Labrador Retrievers with Copper-Associated Hepatitis (2006–2012)
Cardiac Troponin-I Concentration, Myocardial Arteriosclerosis, and Fibrosis in Dogs with Congestive Heart Failure because of Myxomatous Mitral Valve Disease
Effects of Dietary Salt Intake on Renal Function: A 2-Year Study in Healthy Aged Cats
Comparison of Intravenous versus Intramuscular Administration of Corticotropin-Releasing Hormone in Healthy Cats
Renin-Angiotensin-Aldosterone System Activity in Hyperthyroid Cats with and without Concurrent Hypertension
A Potential Role for Substance P and Interleukin-6 in the Cerebrospinal Fluid of Cavalier King Charles Spaniels with Neuropathic Pain
A Prospective Randomized Clinical Trial of Vincristine versus Human Intravenous Immunoglobulin for Acute Adjunctive Management of Presumptive Primary Immune-Mediated Thrombocytopenia in Dogs
Comparison of Sampling Sites and Laboratory Diagnostic Tests for S. equi subsp. equi in Horses from Confirmed Strangles Outbreaks
Physicochemical Interpretation of Acid-Base Abnormalities in 54 Adult Horses with Acute Severe Colitis and Diarrhea
Systemic, Renal, and Colonic Effects of Intravenous and Enteral Rehydration in Horses
Metabolic and Endocrine Profiles in Sick Neonatal Foals Are Related to Survival
Adiposity, Plasma Insulin, Leptin, Lipids, and Oxidative Stress in Mature Light Breed Horses
Identification and Surgical Ligation of Aortopulmonic Vascular Malformation Causing Left Heart Volume Overload in 4 Dogs
Suspected Isolated Pancreatic Enzyme Deficiencies in Dogs
Salt Poisoning as a Cause of Morbidity and Mortality in Neonatal Dairy Calves
Indirect Fluorescent Antibody Test and Surface Antigen ELISAs for Antemortem Diagnosis of Equine Protozoal Myeloencephalitis
Interpretation of Odds and Risk Ratios
C-1 ATRIAL SEPTAL PACING IN SMALL DOGS: A PILOT STUDY.
C-2 EVALUATION OF PACING SITE ON LEFT VENTRICULAR SYNCHRONIZATION USING TWO-DIMENSIONAL (2D) SPECKLE TRACKING STRAIN.
C-3 RADIOFREQUENCY CATHETER ABLATION OF ACCESSORY PATHWAYS IN 58 DOGS.
C-4 LONG TERM FOLLOW-UP AFTER RADIOFREQUENCY ABLATION IN 20 CASES OF ORTHODROMIC ATRIOVENTRICULAR TACHYCARDIA IN UK DOGS.
C-5 THE ROLE OF ACETYLCHOLINE AND THE SINOATRIAL VOLTAGE AND CALCIUM CLOCKS IN THE BEAT-TOBEAT DISTRIBUTION OF THE CANINE SINUS NODE.
C-6 DECREASED RIGHT VENTRICULAR SYSTOLIC FUNCTION IN DOGS WITH MYXOMATOUS MITRAL VALVE DISEASE.
C-7 SEROTONIN MARKERS IN PORCINE MODEL OF CHRONIC MITRAL VALVE REGURGITATION.
C-8 SERIAL EVALUATION OF BIOMARKERS IN ADVANCED CANINE CHRONIC DEGENERATIVE VALVULAR DISEASE.
C-9 PHOSPHODIESTERASE 5A POLYMORPHISMS AND THEIR FUNCTIONAL EFFECTS IN DOGS.
C-10 EFFECT OF LOW-DOSE IMATINIB THERAPY FOR PULMONARY ARTERIAL HYPERTENSION AND HEMODYNAMIC DISTURBANCE CAUSED BY CHRONIC HEART FAILURE IN DOGS.
C-11 MULTICENTERED INVESTIGATION OF NT-proBNP POINT-OF-CARE ELISA ASSAY TO DETECT MODERATE TO SEVERE OCCULT (ASYMPTOMATIC) FELINE HEART DISEASE.
C-12 NT-proBNP MEASURED IN PLEURAL FLUID DIFFERENTIATES CARDIAC FROM NON-CARDIAC CAUSES OF PLEURAL EFFUSION IN CATS.
C-13 EFFECTS OF DEXMEDETOMIDINE ON THE ECHOCARDIOGRAM AND CIRCULATING CARDIAC BIOMARKER CONCENTRATIONS OF NORMAL CATS.
C-14 DETERMINING THE RESPONSIVENESS OF THE CATS' ASSESSMENT TOOL FOR CARDIAC HEALTH (CATCH) QUESTIONNAIRE.
C-15 OUTCOME OF 174 RAGDOLL CATS TESTED FOR THE MYOSIN BINDING PROTEIN C3 MUTATION.
C-16 BIOANALYTICAL METHOD VALIDATION OF A SECOND-GENERATION IMMUNOASSAY FOR THE QUANTIFICATION OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN FELINE BLOOD.
C-17 USE OF A MYOSTATIN ANTAGONIST TO COMBAT CARDIAC CACHEXIA IN DOGS WITH CONGESTIVE HEART FAILURE.
C-18 AN UPDATE ON COMBINED CUTTING BALLOON AND HIGH PRESSURE BALLOON VALVULOPLASTY FOR DOGS WITH SEVERE SUBAORTIC STENOSIS.
C-19 DETECTION OF CIRCULATING MICROPARTICLES IN DOGS.
C-20 MYOCARDIAL PERFORMANCE INDEX IN DOBERMAN PINSCHERS WITH DILATED CARDIOMYOPATHY.
C-21 COMPARISON OF THE ALIVECOR® ECG DEVICE FOR THE iPHONE WITH A REFERENCE STANDARD ELECTROCARDIOGRAM.
C-22 TIME-DOMAIN HEART RATE VARIABILITY IN DOGS WITH SEPSIS.
C-23 USE OF TRANSESOPHAGEAL ECG TO GUIDE PLACEMENT OF A TRANSESOPHAGEAL PACING CATHETER TO THE OPTIMAL PACING SITE.
C-24 EVALUATION OF SERUM BIOMARKERS OF COLLAGEN TURNOVER IN CATS WITH HYPERTROPHIC CARDIOMYOPATHY.
C-25 VIBRATION EFFECT ON INTERSTITIAL CELLS OF THE CANINE MITRAL VALVE.
C-26 EFFECTS OF CATHETER SHAPE, ELECTRODE SIZE AND INTERELECTRODE SPACING ON TRANSESOPHAGEAL ATRIAL PACING IN DOGS.
C-27 BIOLOGICAL VARIABILITY AND CRITICAL CHANGE VALUES FOR ULTRASENSITIVE CARDIAC TROPONIN-I AND NT-proBNP ARE LOWER IN DOGS WITH CARDIAC DISEASE THAN IN HEALTHY CONTROL DOGS.
C-28 INFLUENCE OF BETA BLOCKERS ON SURVIVAL IN DOGS WITH SEVERE SUBAORTIC STENOSIS.
C-29 COMPARATIVE STUDY OF ARTERIAL BLOOD PRESSURE OBTAINED BY DIFFERENT NON-INVASIVE METHODS IN NON-SEDATED NEW ZEALAND WHITE RABBITS.
C-30 INFLUENCE OF R-R INTERVAL VARIATIONS ON THE DEGREE OF MITRAL REGURGITATION IN DOGS WITH MYXOMATOUS MITRAL VALVE DISEASE.
C-31 EVALUATION OF NT-PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) AS A PROGNOSTIC INDICATOR OF SHORT-TERM OUTCOME IN CATS WITH HEART FAILURE.
C-32 CARDIAC BIOMARKERS IN HYPERTHYROID CATS.
C-33 EFFECT OF IVABRADINE, A NOVEL IF CURRENT INHIBITOR, ON DYNAMIC OBSTRUCTION OF THE LEFT VENTRICULAR OUTFLOW TRACT IN CATS WITH PRECLINICAL HYPERTROPHIC CARDIOMYOPATHY: A SINGLE-DOSE STUDY.
C-34 DEVELOPMENT OF SYSTEMIC HYPERTENSION AFTER ADMINISTRATION OF TOCERANIB PHOSPHATE (PALLADIA®) IN DOGS (2010-2012).
C-35 BIOANALYTICAL METHOD VALIDATION OF A SECOND-GENERATION IMMUNOASSAY FOR THE QUANTITATION OF NT-proBNP IN CANINE BLOOD.
C-36 SAFETY OF ORAL ADMINISTRATION OF SPIRONOLACTONE IN CATS WITH HEART FAILURE: INTERIM RESULTS OF THE SEISICAT STUDY.
C-37 NEW RADIOGRAPHIC MEASUREMENTS OF LEFT ATRIAL SIZE IN DOGS WITH DEGENERATIVE MITRAL VALVE DISEASE: PRELIMINARY STUDY.
C-38 N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE CONCENTRATION IN DOGS WITH RGHIT-SIDED HEART FAILURE.
C-39 ECHOCARDIOGRAPHIC ASSESSMENT OF CARDIAC DIMENSIONS AND SYSTOLIC FUNCTION DURING CANINE PUERPERIUM.
C-40 HIGH-DOSE PIMOBENDAN IN THE TREATMENT OF REFRACTORY HEART FAILURE IN DOGS.
C-41 PHARMACOKINETIC EVALUATION OF A DELAYED-RELEASE PROCAINAMIDE PREPARATION IN DOGS.
C-42 CARDIAC BIOMARKER PROFILES IN DOGS WITH PERICARDIAL EFFUSION.
C-43 LONG-TERM CLINICAL BENEFITS OF PHYSIOLOGIC VDD PACING VERSUS NONPHYSIOLOGIC VVI PACING IN DOGS WITH HIGH-GRADE ATRIOVENTRICULAR BLOCK.
C-44 THE EFFECT OF THE GP IIb/IIIa ANTAGONISTS ABCIXIMAB AND EPTIFIBATIDE ON PLATELET AGGREGATION IN HEALTHY CATS.
C-45 UTILITY OF CIRCULATORY NEUROHORMONES, CARDIAC BIOMARKERS, AND PRO-INFLAMMATORY CYTOKINES IN PREDICTION OF CONGESTIVE HEART FAILURE IN CANINE MYXOMATOUS MITRAL VALVE DISEASE.
C-46 BALLOON VALVULOPLASTY OF TRICUSPID VALVE STENOSIS: A RETROPECTIVE STUDY OF 5 LABRADOR RETRIEVERS.
C-47 EVALUATION OF THE ROLE OF TICK-BORNE DISEASE IN 25 CASES OF HIGH GRADE SECOND DEGREE OR COMPLETE ATRIOVENTRICULAR BLOCK IN DOGS.
C-48 TRANSCATHETER TRISCUPID VALVE REPLACEMENT (TTVR) IN DOGS WITH TRISCUPID DYSPLASIA.
C-49 ANALYTICAL VALIDATION OF A COMMERCIALLY-AVAILABLE HIGH-SENSITIVITY IMMUNOASSAY FOR THE MEASUREMENT OF SERUM CARDIAC TROPONIN I CONCENTRATIONS IN DOGS.
C-50 CONVENTIONAL AND TISSUE DOPPLER DERIVED INDICES IN PREDICTION OF CONGESTIVE HEART FAILURE IN CANINE MYXOMATOUS MITRAL VALVE DISEASE.
C-51 TISSUE DOPPLER EVALUATION IN NON-SEDATED RABBITS DURING DOXORUBICIN TREATMENT.
C-52 CHARACTERIZATION AND CLINICAL SIGNIFICANCE OF VENTRICULAR PREMATURE COMPLEXES IN IRISH WOLFHOUNDS.
C-53 USE OF ALIVECOR HEART MONITOR FOR RATE AND RHYTHM EVALUATION IN CATS.
C-54 ANALYSIS OF 5 CANDIDATE GENES FOR FELINE HYPERTROPHIC CARDIOMYOPATHY MUTATIONS IN THE SPHYNX CAT.
C-55 BRONCHOSCOPIC EVALUATION OF AIRWAY COLLAPSE IN LARGE BREED DOGS WITH CARDIOMEGALY: 5 CASES.
C-56 iPHONE WIRELESS ECG ASSESSED HEART RATE IS BETTER CORRELATED WITH HOLTER MONITOR ASSESSED RATES THAN ROUTINE IN-HOSPITAL MEASURES.
C-57 QT IS INCREASED IN DOGS WITH HEART FAILURE SECONDARY TO CHRONIC DEGENERATIVE MITRAL VALVE DISEASE.
C-58 PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION IN 4 MINIATURE SCHNAUZERS.
C-59 MEASUREMENT OF CARDIAC TROPONIN I IN HEALTHY DOGS AND DOGS WITH DEGENERATIVE MITRAL VALVE DISEASE, CONGENITAL HEART DISEASE, OR ARRHYTHMIAS USING A HIGH-SENSITIVITY IMMUNOASSAY.
C-60 THE EFFECT OF PIMOBENDAN ON THE INCIDENCE OF CARDIAC ARRHYTHMIAS.
C-61 PHARMACOLOGICAL PROFILE OF THE CARDIOACTIVE PROTOTYPE LASSBIO-897: A PRELIMINAR STUDY OF ITS POTENTIAL VASODILATORY ACTIVITY.
C-62 DOPPLER-DERIVED MAXIMUM DP/DT IN DIAGNOSIS OF CONGESTIVE HEART FAILURE IN CANINE MYXOMATOUS MITRAL VALVE DISEASE.
C-63 PHARMACOLOGICAL PROFILE OF THE CARDIOACTIVE PROTOTYPES LASSBIO-294 AND LASSBIO-897: A COMPARATIVE PRELIMINARY STUDY OF THEIR METABOLITES' EFFECTS ON MYOCARDIAL CONTRACTION.
C-64 DISCREPANCIES IN IDENTIFICATION OF LEFT ATRIAL ENLARGEMENT USING LEFT ATRIAL VOLUME VS LEFT ATRIAL TO AORTIC ROOT RATIO.
C-65 SIMPLE AND EASY MITRAL VALVE REPAIR IN DOGS.
C-66 ASSESSMENT OF LEFT ATRIAL SIZE IN CATS WITH LEFT-SIDED CONGESTIVE HEART FAILURE.
C-67 PREVALENCE, SURVIVAL TIME AND PROGNOSTIC FACTORS OF DOGS WITH ACQUIRED VALVULAR HEART DISEASE: A RETROSPECTIVE STUDY OF 170 CASES (2009-2012).
C-68 HYPERTENSIVE CARDIOMYOPATHY IN DOGS WITH LEISHMANIA INFANTUM (SYN CHAGASY).
E-1 ASSESSMENT AND RELIABILITY OF MEASURING MICROVASCULAR PERFUSION IN NORMAL ADULT CONSCIOUS HORSES.
E-2 ECHOCARDIOGRAPHIC AND ECG FINDINGS IN HORSES WITH EXPERIMENTALLY INDUCED ENDOTOXEMIA.
E-3 PHARMACODYNAMICS OF 4 ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN HORSES.
E-4 COMPARISON OF TWO IMMUNOASSAYS FOR MEASUREMENT OF SERUM INSULIN IN HORSES.
E-5 COMPARISON OF AN ORAL SUGAR TEST AND INTRAVENOUS INSULIN TOLERANCE TEST TO CHARACTERIZE HORSES WITH EQUINE METABOLIC SYNDROME.
E-6 BREED DIFFERENCES IN INSULIN RESPONSES TO ORAL AND INTRAVENOUS GLUCOSE IN HORSES AND PONIES IN MODERATE BODY CONDITION.
E-7 VALIDATION OF A MINIMAL MODEL TO DESCRIBE NON-ESTERIFIED FATTY ACID KINETICS IN HORSES UNDERGOING AN INTRAVENOUS GLUCOSE TOLERANCE TEST.
E-8 RETROSPECTIVE ANALYSIS OF CLINICAL FEATURES AND PROGNOSTIC INDICATORS IN HYPERTRIGLYCERIDEMIC ADULT EQUIDS (1997-2011).
E-9 PLASMA ADRENOMEDULLIN CONCENTRATION AS A PREDICTOR OF SURVIVAL IN CRITICALLY ILL NEONATAL FOALS.
E-10 EFFECTS OF PARENTERAL ANTIMICROBIALS ON THE EQUINE FECAL MICROBIOME INVESTIGATED BY NEXT GENERATION SEQUENCING.
E-11 A COMPARISON BETWEEN PRE- AND POST-EXERCISE ADMINISTRATION OF OMEPRAZOLE IN TREATMENT OF EGUS.
E-12 A COMPARISON OF THREE DOSES OF OMEPRAZOLE IN THE TREATMENT OF GASTRIC ULCERATION IN THROUGHBRED RACEHORSES.
E-13 MATERNAL T-LYMPHOCYTES IN EQUINE COLOSTRUM.
E-14 CLINICAL AND SEROLOGIC DIAGNOSIS OF BESNOITIOSIS IN DONKEYS.
E-15 INTERRATER RELIABILITY OF THE EQUINE NEUROLOGIC EXAMINATION.
E-16 TEMPORAL TRENDS IN PREVALENCE AND IN-VITRO ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF BACTERIA ISOLATED FROM SEPTIC FOALS: 1979–2010.
E-17 PHARMACOKINETICS OF INTRAVENOUS AND NEBULIZED LIPOSOME-ENCAPSULATED GENTAMICIN SULFATE IN FOALS.
E-18 ASSOCIATION BETWEEN EXERCISE-INDUCED PULMONARY HAEMORRHAGE AND CAREER PERFORMANCE IN THOROUGHBRED RACE HORSES.
E-19 ECHOCARDIOGRAPHIC MEASUREMENTS IN NORMAL NORWEGIAN COLD BLOODED TROTTERS AND ASSOCIATIONS WITH AGE, SEX AND RACE PERFORMANCE.
E-20 RISKS FACTORS FOR VALVULAR REGURGITATIONS IN 3499 EQUIDS: A CROSS-SECTIONAL STUDY.
E-21 ORTHOGONAL ECG LEAD Y AND AIR QUALITY IN RACEHORSE STABLES.
E-22 CHANGES IN INTESTINAL MUCOSAL MICROVASCULAR PERFUSION ASSESSED USING ORTHOGONAL POLARIZATION SPECTRAL IMAGING IN THE HORSE.
E-23 VALIDATION OF THREE DIFFERENT NON-INVASIVE DEVICES TO ASSESS ARTERIAL BLOOD PRESSURE IN STANDING AND NON-SEDATED HORSES.
E-24 HYPERINSULINAEMIA DOWNREGULATES TOLL-LIKE RECEPTOR 4 IN THE EQUINE HEART.
E-25 ASSOCIATION OF HYPERLACTATEMIA WITH ALDOSTERONE AND ARGININE VASOPRESSIN CONCENTRATIONS AND CLINICAL INDICATORS OF HYPOPERFUSION IN HOSPITALIZED FOALS.
E-27 ASSESSMENT OF COMPOUNDED THYROTROPIN RELEASING HORMONE FOR THE DIAGNOSIS OF PITUITARY PARS INTERMEDIA DYSFUNCTION IN HORSES.
E-28 ACUPUNCTURE AND HERBAL MEDICINE USED FOR TREATMENT OF ANHIDROSIS.
E-29 A COMPARISON OF TWO DOSES OF OMEPRAZOLE IN THE PREVENTION OF SQUAMOUS EGUS: A RANDOMIZED, BLINDED STUDY.
E-30 EVALUATION OF SERUM FOLATE, COBALAMIN, AND METHYLMALONIC ACID CONCENTRATIONS IN HORSES WITH EQUINE PROLIFERATIVE ENTEROPATHY AND POSITIVE TITERS FOR LAWSONIA INTRACELLULARIS.
E-31 VENTRAL ABDOMINAL PRESSURES IN HORSES WITH ACUTE COLIC PRESENTING TO A REFERRAL HOSPITAL.
E-32 STANDARDIZATION OF EXPERIMENTAL SMALL COLON OBSTRUCTION IN HORSES.
E-33 THE EFFECT OF ENDOTOXIN ON VISCOELASTIC AND STANDARD COAGULATION PARAMETERS IN HORSES.
E-34 COLIC FOLLOWING SNAKE ENVENOMATION IN HORSES.
E-35 THE EFFECT OF CLOPIDOGREL ON CLINICAL, CELLULAR AND HEMOSTATIC PARAMETERS DURING EXPERIMENTAL ENDOTOXEMIA IN HORSES.
E-36 INTESTINAL COLONIZATION OF NEWBORN FOALS CHARACTERIZED BY NEXT GENERATION SEQUENCING.
E-37 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) TUBE PLACEMENT IN HORSES.
E-38 EFFECT OF N-BUTYLSCOPOLAMMONIUM BROMIDE ON ENEMA RETENTION IN HEALTHY ANESTHETIZED FOALS.
E-41 ACTIVATION OF TOLL-LIKE RECEPTOR SIGNALING IN EQUINE HYPERINSULINAEMIC LAMINITIS.
E-42 DIFFERENCES IN EQUINE PULMONARY IMMUNE RESPONSE TO RHODOCOCCUS EQUI IN FOALS VERSUS ADULTS.
E-43 LEUCOCYTE CITOKINE EXPRESSION IN HORSES DURING AN 80KM ENDURANCE RIDE.
E-44 EFFICACY OF LIPOSOME-ENCAPSULATED GENTAMICIN FOR THE TREATMENT OF RHODOCOCCUS EQUI IN A MOUSE INFECTION MODEL.
E-45 EQUINE GRANULOCYTIC ANAPLASMOSIS AND LYME DISEASE EXPOSURE IN HORSES IN CANADA.
E-46 RISK FACTORS FOR ENVIRONMENTAL CONTAMINATION WITH SALMONELLA ENTERICA IN A VETERINARY TEACHING HOSPITAL.
E-47 EMERGING OUTBREAKS ASSOCIATED WITH EQUINE CORONAVIRUS IN ADULT HORSES.
E-48 RHODOCOCCUS EQUI – A NEW MODEL FOR A BETTER UNDERSTANDING OF AN OLD DISEASE.
E-49 EVALUATION OF A NUCLEIC ACID HYBRIDIZATION TEST (GENEQUENCE®) FOR IDENTIFICATION OF SALMONELLA SPP IN EQUINE FECES AND ENVIRONMENTAL SAMPLES.
E-50 EFFECTS OF INTRAVENOUS POLYMYXIN B ADMINISTRATION IN AN ENDOTOXEMIA MODEL IN NEONATAL FOALS.
E-51 POOLING OF FECES AND ENVIRONMENTAL SAMPLES FOLLOWING A SELECTIVE ENRICHMENT CULTURE STEP FOR THE DETECTION OF SALMONELLA SPP. BY REAL-TIME PCR.
E-52 PREVALENCE AND STRAIN CHARACTERIZATION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS FROM EQUINE NASOPHARYNGEAL AND GUTTURAL POUCH WASH SAMPLES.
E-53 ENVIRONMENTAL SURVIVAL OF EQUID HERPESVIRUS TYPE 1 (EHV-1).
E-54 VERIFICATION OF A STREPTOCOCCUS EQUI DETECTION ASSAY FOR EQUINE NASOPHARYNGEAL AND GUTTURAL POUCH WASHES SAMPLES.
E-55 CLINICAL SIGNS, NEUROBEHAVIORAL SCORE, AND ELECTROENCEPHALOGRAM RECORDINGS ASSOCIATED WITH INFUSION OF A PREGNENOLONE DERIVATIVE TO INDUCE NEONATAL MALADJUSTMENT SYNDROME.
E-56 REDUCED THRESHOLD POTENTIAL OF THE TRIGEMINAL NERVE IN EQUINE HEADSHAKING.
E-57 BIOMECHANICS IN ATAXIC HORSES.
E-58 TREATMENT OF IDIOPATHIC HEADSHAKING IN THE HORSE WITH PULSED HIGH DOSE DEXAMETHASONE.
E-59 PREVALENCE AND RISK FACTORS ASSOCIATED WITH EXERTIONAL RHABDOMYOLYSIS IN AUSTRALIAN POLOCROSSE HORSES.
E-60 LAMELLAR BIOENERGETICS STUDIED USING TISSUE MICRODIALYSIS.
E-61 ULTRAFILTRATION OF EQUINE DIGITAL LAMELLAR TISSUE.
E-62 OPTIMISATION AND CHARACTERISATION OF A CONDITIONALLY- IMMORTALISED EQUINE SKELETAL MUSCLE CELL LINE.
E-63 CHANGES IN SERUM PROTEINS CONCENTRATIONS IN HORSES SUBMITTED TO AN 80KM ENDURANCE RIDE.
E-64 MUTATIONAL ANALYSIS AND FACTOR VIII SEQUENCE IN A COLT WITH HEMOPHILIA A.
E-65 SERUM PROTEIN CONCENTRATION IN HORSES AFTER 160KM, 120KM AND 80KM ENDURANCE RIDE.
E-66 CONCENTRATIONS OF DESFUROYLCEFTIOFUR ACETAMIDE AFTER WEEKLY ADMINISTRATION OF CEFTIOFUR CRYSTALLINE FREE ACID TO ADULT HORSES AND COMPARATIVE PHARMACOKINETICS OF THE DRUG AFTER INTRAMUSCULAR VERSUS SUBCUTANEOUS ADMINISTRATION.
E-67 COMPARISON OF MELOXICAM AND PHENYLBUTAZONE ON LIPOPOLYSACCHARIDE INDUCED SYNOVITIS IN HORSES.
E-68 DISPOSITION OF LEVETIRACETAM IN HEALTHY ADULT HORSES.
E-69 EFFECT OF BODY WEIGHT ON THE PHARMACOKINETICS OF FLUNIXIN MEGLUMINE IN MINIATURE HORSES AND QUARTER HORSES.
E-70 LOW EFFICACY OF WORMERS ARE NOT ALWAYS A CHEMORESISTANCE PROBLEM.
E-71 COMPARISON OF RADIOGRAPHIC AND COMPUTER TOMOGRAPHY IMAGES OF THE LUNG IN HEALTHY NEONATAL FOALS.
E-72 THE EFFECT OF CHRONIC CLENBUTEROL ADMINISTRATION ON MUCOCILIARY CLEARANCE AND REPARTITIONING IN ADULT HORSES.
E-73 COMPARISON OF THE EFFICACY AND SIDE-EFFECTS OF N-BUTYLSCOPOLAMMONIUM BROMIDE AND ATROPINE IN THE TREATMENT OF HORSES WITH HEAVES.
E-74 PRELIMINARY EXPERIENCES WITH CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) FOR RESPIRATORY INSUFFICIENCY IN BOVINE AND EQUINE NEONATES.
F-1 USE OF THE PHYSICOCHEMICAL APPROACH TO CHARACTERIZE ACID-BASE ABNORMALITIES IN 264 CALVES WITH NATURALLY ACQUIRED DIARRHEA.
F-2 COMPARISON OF FIVE QUANTITATIVE DIFFERENT METHODS FOR ESTIMATING PLASMA UNMEASURED ANIONS AND THEIR CORRELATION WITH L-LACTATE, AND DETERMINATION OF THE PREDICTIVE VALUE OF L-LACTATE FOR MORTALITY IN 20 DIARRHEIC CALVES.
F-3 INVESTIGATION OF THE RELATIONSHIP BETWEEN METABOLIC STRONG ION ACIDOSIS AND DEMEANOUR IN 264 CALVES WITH NEONATAL DIARRHEA.
F-4 VALIDATION OF ULTRASOUND IMAGING TECHNIQUE OF TYMPANIC BULLA FOR DIAGNOSIS OF OTITIS MEDIA IN CALVES.
F-5 GENOTYPIC CHARACTERIZATION OF STAPHYLOCOCCUS CHROMOGENES ISOLATED FROM CASES OF BOVINE MASTITIS.
F-6 CEREBROSPINAL FLUID FINDINGS IN NORMAL AND CONFIRMED CASES OF OTITIS MEDIA IN CALVES.
F-7 PROGNOSTIC FACTORS ASSOCIATED WITH SURVIVAL OF DOES AND KIDS IN PREGNANCY TOXEMIA: A RETROSPECTIVE STUDY OF 56 CASES.
F-8 EVALUATION OF SERUM VITAMIN E AND CHOLESTEROL LEVELS IN ALPACAS.
F-9 ARSENIC TOXICOSIS IN CATTLE: META-ANALYSIS OF 156 CASES AND IDENTIFICATION OF FACTORS FOR A POSITIVE OUTCOME.
F-10 DEVELOPMENT OF BACTEREMIA IN THE PEDAL CIRCULATION FOLLOWING REGIONAL INTRAVENOUS PERFUSION OF 2% LIDOCAINE IN CATTLE WITH DEEP DIGITAL SEPSIS.
F-11 ULTRASONOGRAPHIC PROGRESSION OF LUNG CONSOLIDATION AFTER EXPERIMENTAL INFECTION WITH MANNHEIMIA HAEMOLYTICA IN HOLSTEIN CALVES.
F-12 EVALUATION OF HAPTOGLOBIN IN EXHALED BREATH CONDENSATE OF HOLSTEIN CALVES FOLLOWING EXPERIMENTAL INFECTION WITH MANNHEIMIA HAEMOLYTICA.
N-1 QUANTITATIVE ASSESSMENT OF HSP70, IL-1ß AND TNF-A IN SPINAL FLUID AND SPINAL CORD SECTIONS OF DOGS WITH HISTOPATHOLOGICALLY CONFIRMED DEGENERATIVE MYELOPATHY AND CONTROL DOGS.
N-2 CLINICAL PROGRESSION OF CANINE DEGENERATIVE MYELOPATHY.
N-3 MESENCHYMAL STEM CELL INJECTION INTO THE SPINAL CORD OF 2 DOGS WITH DEGENERATIVE MYELOPATHY: A PHASE 1 TOXICITY TRIAL.
N-4 CLINICAL AND IMAGING FINDINGS ASSOCIATED WITH BRAIN HERNIATION IN DOGS AND CATS.
N-5 INTRAMEDULLARY SPINAL CORD NEOPLASIA IN 53 DOGS (1990-2010): INCIDENCE, PHENOTYPE, AND CLINICAL BEHAVIOR.
N-6 INVESTIGATION OF MOLECULAR SIGNALING PATHWAYS IN CANINE PRIMARY GLIOMAS.
N-7 MUSCULAR DYSTROPHY IN JAPANESE SPITZ: DESCRIPTION OF THE MUTATION AND CARRIER DETECTION USING POLYMERASE CHAIN REACTION.
N-8 A COMPARISON OF COMBINATION THERAPY (PREDNISONE PLUS CYTOSINE ARABINOSIDE) WITH PREDNISONE THERAPY ALONE IN DOGS WITH MENINGOENCEPHALOMYELITIS OF UNKNOWN ETIOLOGY.
N-9 MIP-3b/CCL19 ASSOCIATED WITH THE INVASION OF MONONUCLEAR CELLS IN NEUROINFLAMMATORY AND NON-NEUROINFLAMMATORY DISEASES IN DOGS.
N-10 ACUTE DISTEMPER VIRUS INFECTION REDUCES ROS GENERATION OF EX VIVO CULTIVATED CANINE MONOCYTES.
N-11 JOINT-ASSOCIATED CERVICAL SPONDYLOMYELOPATHY: 27 CASES (2000-2012).
N-12 MORPHOMETRIC MAGNETIC RESONANCE IMAGING FEATURES OF THE CERVICAL VERTEBRAL COLUMN OF GREAT DANES WITH AND WITHOUT CLINICAL SIGNS OF CERVICAL SPONDYLOMYELOPATHY.
N-13 MORPHOLOGIC MAGNETIC RESONANCE IMAGING FEATURES OF THE CERVICAL VERTEBRAL COLUMN OF GREAT DANES WITH AND WITHOUT CLINICAL SIGNS OF CERVICAL SPONDYLOMYELOPATHY.
N-14 CERVICAL DISC ARTHROPLASTY USING THE ADAMO SPINAL DISC IN 18 DOGS AFFECTED BY DISC ASSOCIATED WOBBLER SYNDROME.
N-15 EVALUATION OF TWO METHODS OF SURGICAL STABILIZATION FOR THE ATLANTOAXIAL JOINT.
N-17 HEPARAN SULFATE PROTEOGLYCAN GENE EXPRESSION AND INFLAMMATION IN THE CEREBRAL CORTEX FOLLOWING LUNG INJURY.
N-18 DETERMINATION OF STABILITY AND STORAGE PARAMETERS FOR OPTIMAL DETECTION OF CREATINE KINASE AND ITS ISOENZYMES IN CANINE SERUM AND CEREBROSPINAL FLUID.
N-19 ACTIVITY AND DISTRIBUTION OF LACTATE DEHYDROGENASE AND ITS ISOENZYMES IN THE SERUM AND CEREBROSPINAL FLUID OF HEALTHY CANINES.
N-20 PRIMARY HEMATOMYELIA IN THREE DOGS
N-21 COMBINED DORSAL AND VENTRAL STABILIZATION IN TRACTION RESPONSIVE CERVICAL SPONDYLOMYELOPATHY.
N-22 THERAPEUTIC SERUM PHENOBARBITAL LEVELS IN CATS.
N-23 KINETIC AND KINEMATIC FOLLOW-UP GAIT ANALYSIS IN DOBERMAN PINCHERS WITH CERVICAL SPONDYLOMYELOPATHY TREATED MEDICALLY AND SURGICALLY.
N-24 INHERITANCE OF CERVICAL SPONDYLOMYELOPATHY IN DOBERMAN PINSCHERS.
N-25 MAGNETIC RESONANCE IMAGING FINDINGS IN A CANINE MODEL OF INTRACEREBRAL HEMORRHAGE.
N-26 DETERMINATION OF STABILITY AND STORAGE PARAMETERS FOR OPTIMAL DETECTION OF LACTATE DEHYDROGENASE AND ITS ISOENZYMES IN CANINE SERUM AND CEREBROSPINAL FLUID.
N-27 COMPARISON OF NON-CONTRAST COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF GREAT DANES WITH CERVICAL SPONDYLOMYELOPATHY.
O-1 INVESTIGATING ZOLEDRONATE INDUCTION OF APOPTOSIS AND COMBINATION WITH CHEMOTHERAPY AGAINST OSTEOSARCOMA.
O-2 NEUTROPHIL FUNCTION IN DOGS WITH LYMPHOMA TREATED WITH CHEMOTHERAPY.
O-3 CK2 INHIBITION IN FELINE CANCER CELL LINES USING SYNTHETIC OLIGONUCLEOTIDES.
O-4 THE INFLUENCE OF SURVIVIN INHIBITION ON INHIBITORY ACTIVITY AGAINST CANINE HISTIOCYTIC SARCOMA CELL LINES.
O-5 SIGNIFICANCE OF A DIAGNOSTIC APPROACH BY USING SURFACE ANTIGENMRNA EXPRESSION ANALYSIS IN 8 DOGS WITH HISTIOCYTIC SARCOMA.
O-6 ELECTRO-GENE-TRANSFER (EGT) AS A NEW TOOL FOR CANCER IMMUNOTHERAPY IN ANIMALS.
O-7 RELATIONSHIP BETWEEN SYSTEMIC INFLAMMATORY RESPONSE (CRP AND HP) AND LOCAL INFLAMMATORY RESPONSE (COX-2 EXPRESSION) IN CANINE MAMMARY TUMOURS.
O-8 THE EFFECTS OF SULFORAPHANE ON NEOPLASTIC CELL PROLIFERATION AND DEATH.
O-9 TARGETING LYMPHOID PROGENITOR CELLS IN CANINE B-CELL LYMPHOMA USING NEOADJUVANT ABCB1 TRANSPORTER INHIBITION AND DOXORUBICIN CHEMOTHERAPY.
O-10 RELATIONSHIP BETWEEN AGE AND MALIGNANT AND BENIGN SPLENIC MASSES IN DOGS: 50 CASES (2009-2012).
O-11 STRATEGIES FOR SIGNAL BLOCKADE IN FELINE ORAL SQUAMOUS CELL CARCINOMA.
O-12 EFFECTS OF SEQUENTIAL COMBINATION CHEMOTHERAPY ON THE FECAL MICROBIOME IN DOGS WITH LYMPHOMA.
O-13 EXPRESSION OF ADIPONECTIN RECEPTOR 1 IN CANINE TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
O-14 EFFECTS OF CRIZOTINIB ON CANINE OSTEOSARCOMA MIGRATION AND INVASION.
O-15 SAFETY EVALUATION OF SYSTEMIC ADMINISTRATION WITH A NEW PHOTOSENSITIZER IN NORMAL DOGS.
EN-1 PASIREOTIDE (SOM230) OPENS DOORS TO MEDICAL MANAGEMENT OF FELINE HYPERSOMATOTROPISM.
EN-2 ECTOPIC SUBLINGUAL THYROID NEOPLASIA IN THE DOG: 25 CASES (1995-2012).
EN-3 USE OF L-THYROXINE SUPPLEMENTATION AFTER RADIOIODINE THERAPY HELPS BLUNT THE WORSENING OF AZOTEMIA IN HYPERTHYROID CATS WITH PRE-EXISTING KIDNEY DISEASE.
EN-4 INVESTIGATION OF THE PATHOPHYSIOLOGICAL MECHANISM FOR ALTERED CALCIUM HOMEOSTASIS IN HYPERTHYROID CATS.
EN-5 EIGHT NOVEL POLYMORPHISMS IDENTIFIED IN THE FELINE CALCIUM SENSING RECEPTOR IN CATS WITH VARYING PLASMA IONISED CALCIUM CONCENTRATIONS.
EN-6 STEREOTACTIC RADIATION THERAPY FOR CANINE PITUITARY DEPENDENT HYPERADRENOCORTICISM.
EN-7 SUPPRESSION OF SERUM ALDOSTERONE FOLLOWING ORAL ADMINISTRATION OF FLUDROCORTISONE ACETATE IN HEALTHY CATS.
EN-8 COMPARISON OF DIAGNOSTIC TESTS AND TREATMENT OPTIONS FOR FELINE HYPERADRENOCORTICISM: A RETROSPECTIVE REVIEW OF 32 CASES.
EN-9 IN VITRO ELEVATION OF MEAN CORPUSCULAR VOLUME AS A MARKER FOR SERUM HYPEROSMOLALITY IN DOGS.
EN-10 URINARY AND PLASMA CATECHOLAMINE AND METANEPHRINE IN DOGS WITH PHEOCHROMOCYTOMA, HYPERADRENOCORTICISM AND IN HEALTHY DOGS.
EN-11 ABDOMINAL ULTRASOUND FINDINGS IN ACROMEGALIC CATS.
EN-12 PREVALENCE AND RISK FACTORS FOR HYPERTHYROIDISM IN IRISH CATS FROM THE GREATER DUBLIN AREA.
EN-13 ADRENOCORTICAL RESPONSE TO ACTH STIMULATION TEST IN DOGS NATURALLY INFECTED BY EHRLICHIA CANIS.
EN-14 P450 SIDE-CHAIN CLEAVAGE ENZYME AUTOANTIBODIES IN DOGS WITH RECENTLY DIAGNOSED HYPOADRENOCORTICISM.
EN-15 EVALUATION OF SERUM ADIPOKINE CONCENTRATIONS IN DOGS WITH NATURALLY OCCURRING PITUITARY-DEPENDENT HYPERADRENOCORTICISM.
EN-16 QUALITATIVE EVALUATION OF URINARY PROTEINS BY SODIUM DODECYL SULPHATE POLYACRILAMIDE GRADIENT GEL ELECTROPHORESIS (SDS-PAGE) DURING THE TREATMENT OF DOGS WITH HYPERADRENOCORTICISM (HAC).
EN-17 EVALUATION OF CIRCULATING LEVELS OF CHOLECYSTOKININ IN DOGS WITH NATURALLY OCCURRING PITUITARY-DEPENDENT HYPERADRENOCORTICISM.
EN-18 DOSING OBESE CATS ON A PER KG BASIS AFFECTS SOME MEASURES OF GLUCOSE TOLERANCE IN A GLUCOSE TOLERANCE TEST.
EN-19 ADRENAL GLAND ULTRASONOGRAPHY IN DOGS WITH HYPOADRENOCORTICISM.
EN-20 EVALUATION OF THYROID-STIMULATING HORMONE, TOTAL THYROXINE AND FREE THYROXINE CONCENTRATIONS IN 65 HYPERTHYROID CATS RECEIVING METHIMAZOLE THERAPY.
EN-21 PERFLUORINATED COMPOUNDS (PFCS) IN SERUM OF CATS – LINKAGE TO INDOOR EXPOSURES.
EN-22 EFFECTS OF COMBINED ADMINISTRATION OF CYCLOSPORINE AND PREDNISONE ON SERUM GLUCOSE CONCENTRATIONS.
EN-23 DIAGNOSIS OF PREDIABETES IN CATS: CUTPOINTS FOR IMPAIRED FASTING GLUCOSE AND IMPAIRED GLUCOSE TOLERANCE IN CATS 8 YEARS AND OLDER USING EAR OR PAW SAMPLES AND A PORTABLE GLUCOSE METER CALIBRATED FOR CATS.
EN-24 EVALUATION OF A HIGH YIELD TECHNIQUE FOR PANCREATIC ISLET ISOLATION FROM DOG CADAVERS.
EN-25 EFFECTS OF KETONES AND LACTATE ON SERUM TONICITY ASSESSED USING A CANINE RED BLOOD CELL ASSAY.
EN-26 QUALITATIVE AND QUANTITATIVE EVALUATION OF URINARY PROTEINS BY SODIUM DODECYL SULPHATE POLYACRILAMIDE GEL ELECTROPHORESIS (SDSPAGE) AND ALBUMIN-TO-CREATININE RATIO IN DOGS WITH DIABETES MELLITUS.
EN-27 MUTATIONS IN FELINE ARGININE VASOPRESSIN IN CATS WITH CENTRAL DIABETES INSIPIDUS.
EN-28 INVESTIGATION OF BASAL AND POSTPRANDIAL HYPERTRIGLYCERIDEMIA AND INSULIN RESISTANCE IN HEALTHY MINIATURE SCHNAUZERS.
EN-29 THERAPY OF CANINE HYPERLIPIDEMIA WITH BEZAFIBRATE.
EN-30 DISTRIBUTION OF K AND L CELLS IN THE INTESTINES OF NORMAL CATS.
EN-31 PEPTIDE YY AND GLUCAGON LIKE PEPTIDE-1 IN LEAN AND OBESE CATS.
GI-1 EFFECT OF PANCREATIC BIOPSY ON SERUM CONCENTRATIONS OF FELINE PANCREATIC LIPASE IMMUNOREACTIVITY.
GI-2 EVALUATION OF SERUM SPEC FPLTM AND 1,2-O-DILAURYL-RAC-GLYCERO-3-GLUTARIC ACID-(6'-METH-YLRESORUFIN) ESTER (DGGR) LIPASE IN 40 CATS WITH STANDARDIZED PANCREATIC HISTOPATHOLOGICAL ASSESSMENT.
GI-3 EVALUATION OF CANINE PANCREAS-SPECIFIC LIPASE (SPEC CPL®) CONCENTRATION AND, AMYLASE AND LIPASE ACTIVITIES IN PERITONEAL FLUID AS COMPLEMENTARY DIAGNOSTIC TOOLS FOR ACUTE PANCREATITIS IN DOGS.
GI-4 ASSOCIATION BETWEEN CHRONIC PANCREATITIS AND DOG LEUKOCYTE ANTIGEN HAPLOTYPES IN THE ENGLISH COCKER SPANIEL.
GI-5 AGREEMENT OF SERUM SPEC FPLTM WITH PANCREATIC ULTRASONOGRAPHIC FINDINGS IN CATS WITH SUSPICION OF PANCREATITIS.
GI-6 EVALUATION OF THE EFFECT OF ORAL CISAPRIDE ON LOWER ESOPHAGEAL SPHINCTER PRESSURE IN AWAKE DOGS USING HIGH-RESOLUTION MANOMETRY.
GI-7 EVALUATION OF THE FECAL MICROBIOTA IN DOGS WITH IDIOPATHIC INFLAMMATORY BOWEL DISEASE BEFORE AND AFTER TREATMENT.
GI-8 FECAL MICROFLORA AND FECAL SCORE IN CATS FOLLOWING DIETARY THERAPY FOR CHRONIC DIARRHEA.
GI-9 MORTALITY IN FOSTER-AGE KITTENS IS ASSOCIATED WITH A SHIFT FROM ILEUM MUCOSA-ASSOCIATED ENTEROCOCCUS HIRAE TO COLONIZATION BY E. FAECALIS AND ENTEROPATHOGENIC E. COLI.
GI-10 FEASIBILITY OF CONFOCAL ENDOMICROSCOPY FOR IN VIVO HISTOLOGICALLY-EQUIVALENT EVALUATION OF GASTRIC MUCOSAL TOPOLOGIC MORPHOLOGY IN CLINICALLY HEALTHY DOGS.
GI-11 INTER- AND INTRA-OBSERVER AGREEMENT IN THE ENDOSCOPIC ASSESSMENT OF CANINE INFLAMMATORY BOWEL DISEASE.
GI-12 ANALYTICAL ASSESSMENT OF SERUM LIPOPROTEIN PROFILES IN HEALTHY DOGS AND DOGS WITH EXOCRINE PANCREATIC INSUFFICIENCY.
GI-13 SERUM HOMOCYSTEINE CONCENTRATIONS IN DOGS WITH CHRONIC ENTEROPATHIES.
GI-14 CYSTEINE PROTEASES OF FELINE T. FOETUS MEDIATE ADHESION AND CYTOPATHOGENICITY TO INTESTINAL EPITHELIAL CELLS.
GI-15 EVALUATION OF THE ABUNDANCE OF BLAUTIA SPP., FUSOBACTERIUM SPP., AND FAECALIBACTERIUM SPP. IN FECES FROM DOGS WITH ACUTE HEMORRHAGIC DIARRHEA.
GI-16 SERUM SOLUBLE RAGE CONCENTRATIONS ARE DECREASED IN DOGS WITH IDIOPATHIC INFLAMMATORY BOWEL DISEASE.
GI-17 WHAT IS THE NUMBER OF DAILY BOWEL MOVEMENTS IN NORMAL PRIVATELY-OWNED DOGS?.
GI-18 EXPRESSION OF CLAUDINS PROTEIN IN THE DUODENAL MUCOSA FROM DOGS WITH INFLAMMATORY BOWEL DISEASE.
GI-19 ANALYTICAL VALIDATION OF A COMMERCIALLY AVAILABLE RADIOIMMUNOASSAY KIT FOR THE MEASUREMENT OF FECAL CORTISOL CONCENTRATIONS IN DOGS.
GI-20 ASSESSMENT OF THE EFFECT OF A NOVEL NUTRITIONAL SUPPLEMENT ON THE FECAL MICROBIOTA IN HEALTHY DOGS.
GI-21 SEROTONIN AND CHROMOGRANIN-A EXPRESSION IS INCREASED IN THE SMALL INTESTINE OF DOGS WITH INFLAMMATORY BOWEL DISEASE.
GI-22 CAUSES OF ACUTE AND CHRONIC REGURGITATION IN 43 DOGS (2010-2012).
GI-23 CONFOCAL ENDOMICROSCOPIC EVALUATION OF THE CANINE COLON.
GI-24 FEASIBILITY OF CONFOCAL ENDOMICROSCOPY FOR IN VIVO HISTOLOGICALLY-EQUIVALENT EVALUATION OF SMALL INTESTINAL MUCOSAL TOPOLOGIC MORPHOLOGY IN CLINICALLY HEALTHY DOGS.
GI-25 SAFETY AND PALATABILITY OF HIGH DOSE PROBIOTIC (VSL#3) IN HEALTHY CATS.
GI-26 ASSESSMENT OF FEASIBILITY OF WSAVA GASTROINTESTINAL STANDARDIZATION GROUP TEMPLATE IN DIFFERENT ANATOMICAL REGIONS OF THE GASTROINTESTINAL TRACT IN 9 HEALTHY CATS.
GI-27 SUCRALFATE PROTECTS AGAINST ACID-INDUCED GASTRIC MUCOSAL BARRIER DYSFUNCTION.
GI-28 PRELIMINARY CLINICAL AND MICROBIOME ASSESSMENT OF STOOL TRANSPLANTATION IN THE DOG AND CAT.
GI-29 BILIOUS VOMITING SYNDROME IN DOGS: RETROSPECTIVE STUDY OF 20 CASES (2002 - 2012).
GI-30 TEMPORAL EFFECT OF THE PERCENTAGE OF WATER INGESTED IN FOOD ON PLASMA CONCENTRATIONS OF GLUCOSE, INSULIN, LACTATE, AND AMINO ACIDS IN THE DOG.
GI-31 INCIDENCE OF HISTOPATHOLOGIC INFLAMMATORY BOWEL DISEASE IN DOGS WITH BILIARY MUCOCELE: A RETROSPECTIVE STUDY (2004-2012).
GI-32 A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE USE OF ENTEROCOCCUS FAECIUM SF68 IN CLIENT-OWNED DOGS RECEIVING DOXORUBICIN CHEMOTHERAPY.
GI-33 MARKED INCREASED EXPRESSION OF INTERLEUKIN 8 IN THE COLORECTAL MUCOSA OF DOGS WITH INFLAMMATORY COLORECTAL POLYPS BUT NOT WITH LYMPHOCYTIC-PLASMACYTIC COLITIS.
GI-34 QUALITATIVE AND QUANTITATIVE CONTRAST ENHANCED ULTRASONOGRAPHIC ASSESSMENT OF CERULEIN-INDUCED PANCREATITIS IN DOGS.
GI-35 AGREEMENT OF THE SERUM SPEC FPLTM AND 1,2-O-DILAURYL-RAC-GLYCERO-3-GLUTARIC ACID-(6'-METH-YLRESORUFIN) ESTER (DGGR) LIPASE ASSAY FOR THE DETERMINATION OF SERUM LIPASE IN CATS WITH SUSPICION OF PANCREATITIS.
GI-36 EFFECT OF SERUM CREATININE ON PANCREATIC LIPASE IMMUNOREACTIVITY IN DOGS WITHOUT ULTRASONOGRAPHIC EVIDENCE OF PANCREATITIS.
GI-37 A PILOT STUDY TO EVALUATE CIRCULATING LEVELS OF RESISTIN IN DOGS WITH ACUTE PANCREATITIS.
GI-38 TOTAL SERUM LIPASE ACTIVITY FOR THE ANTEMORTEM DIAGNOSIS OF FELINE PANCREATITIS.
GI-39 INCREASED FECAL α1-PROTEINASE INHIBITOR CONCENTRATIONS IN DOGS WITH EXOCRINE PANCREATIC INSUFFICIENCY.
GI-40 ULTRASOUND EVALUATION OF THE EFFECTS OF VARIOUS PROKINETICS ADMINISTERED INTRAVENOUSLY ON GASTRIC AND DUODENAL MOTILITY IN HEALTHY DOGS.
HM-1 RIVAROXABAN IS AN EFFICIENT ANTICOAGULANT IN HEALTHY DOGS: TIME COURSE OF HAEMOSTATIC PARAMETERS.
HM-2 A NOVEL CANINE MODEL OF IMMUNE THROMBOCYTOPENIA.
HM-3 THROMBOELASTOGRAPHY IN DOGS WITH GASTRIC DILITATION-VOLVULUS.
HM-4 PREGNANCY IS A HYPERCOAGULABLE STATE IN QUEENS.
HM-5 EFFECTS OF IN-VITRO HEMODILUTION WITH CRYSTALLOIDS, COLLOIDS AND PLASMA ON CANINE WHOLE BLOOD COAGULATION AS DETERMINED BY KAOLIN-ACTIVATED THROMBOELASTOGRAPHY.
HM-6 HEMOPHILIA A IN 41 DOGS.
HM-7 COMPLETE BLOOD CELLS AND RETICULOCYTES COUNT IN CATS WITH INTESTINAL LYMPHOMA.
HM-8 THE PREVALENCE OF ANEMIA IN CRITICALLY ILL DOGS AND CATS: A MULTI-INSTITUTIONAL STUDY.
HM-9 USE OF A NOVEL 13-GAUGE NEEDLE FOR BONE MARROW BIOPSY IN HEALTHY CATS.
HM-10 EFFECT OF LOW-DOSE ASPIRIN OR HEPARIN ON PLATELET-DERIVED URINARY THROMBOXANE METABOLITE IN DOGS WITH IMMUNE-MEDIATED HEMOLYTIC ANEMIA (IMHA).
HM-11 USE OF LIPOSOMAL CLODRONATE TO FACILITATE DETECTION OF SUBCLINICAL INFECTION WITH BABESIA CANIS IN GREYHOUNDS.
HM-12 HEMATOLOGICAL DIFFERENCES BETWEEN DACHSHUNDS AND MIXED BREED DOGS.
HM-13 THE EFFECT OF PLATELET-CONTAINING PRODUCTS ON HEMOSTASIS IN DOGS AFTER TOTAL BODY IRRA-DIATION INDUCED THROMBOCYTOPENIA.
HM-14 THE PROTEOME OF CANINE PLATELET: INSIGHTS ON ITS PHYSIOLOGIC AND PATHOLOGIC ROLES.
HM-15 CONGENITAL FACTOR VII DEFICIENCY IN PAPILLON DOGS.
HM-16 EFFECT OF DURATION OF PACKED RED BLOOD CELL STORAGE ON MORBIDITY AND MORTALITY IN DOGS FOLLOWING TRANSFUSION.
HM-17 COMPATIBILITY OF DOMESTIC CAT BLOOD WITH NON-DOMESTIC FELID BLOOD.
HM-18 EVALUATION OF A FELINE BLOOD TYPING DEVICE (RAPIDVET®-H IC FELINE).
HM-19 EFFECT OF MANUAL OR CHEMICAL (MEDETOMIDINE) RESTRAIN ON RED BLOOD CELLS OR RETICULOCYTES COUNT IN STRAY CATS.
HP-1 THROMBOELASTOGRAPHIC EVALUATION OF DOGS WITH CONGENITAL PORTOSYSTEMIC SHUNTS.
HP-2 A RETROSPECTIVE STUDY OF THE CAUSES AND PROGNOSTIC INDICATORS IN DOGS THAT MEET HY'S LAW CRITERIA (2005-2012).
HP-3 HEPATIC COPPER AND ZINC CONCENTRATIONS IN FERAL DOGS VERSUS DOGS FED A COMMERCIAL DIET.
HP-4 ABSENCE OF PKD1 POINT MUTATION IN CATS WITH HEPATOFIBROCYSTIC DISEASE.
HP-5 HEPATOCELLULAR CARCINOMA/ADENOMA IN 94 DOGS: ASSOCIATION WITH VACUOLAR HEPATOPATHY AND ADRENAL HYPERACTIVITY.
HP-6 EVALUATION OF COBALAMIN STATUS IN DOGS WITH HEPATIC DISEASE.
HP-7 THE EFFECT OF 6-8 WEEKS OF URSODEOXYCHOLIC ACID ADMINISTRATION ON BIOCHEMICAL PARAMETERS AND BILE ACIDS IN HEALTHY CANINES.
HP-8 A COMPARISON OF LIVER BIOPSY TECHNIQUES IN DOGS.
IM-1 AGE-RELATED CHANGES IN LEUKOCYTE GENE EXPRESSION AND CELL POPULATIONS FROM ADULT CATS.
IM-2 IDIOPATHIC IMMUNE-MEDIATED POLYARTHROPATHY IN DOGS: A PILOT STUDY OF SURROGATE MARKERS OF DISEASE.
IM-3 AGE-RELATED CHANGES IN LEUKOCYTE GENE EXPRESSION FROM ADULT DOGS.
IM-4 COMPARISON OF THE EFFICACY OF PREDNISONE AND CYCLOSPORINE FOR TREATMENT OF CANINE PRIMARY IMMUNE-MEDIATED POLYARTHRITIS.
IM-5 STIMULATION WITH CONCANAVALIN-A INDUCES IL-17 PRODUCTION IN CANINE PERIPHERAL T CELLS.
IM-6 INCREASED LEVEL OF CD4 + CD25 + FOXP3 + REGULATORY T CELLS IN THE PERIPHERAL BLOOD OF 7 DOGS WITH IMMUNE-MEDIATED HEMOLYTIC ANEMIA.
IM-7 CANINE STERILE NEUTROPHILIC DERMATITIS IN DOGS RESEMBLING SWEET SYNDROME AND ITS TEMPORAL RELATION TO VACCINATION.
IM-8 A SERIAL CD4 + /CD25 + /FOXP3 + REGULATORY T CELL CHANGES IN CANINE SEPTIC MODEL.
IM-9 DEVELOPMENT & VALIDATION OF NOVEL MULTIPLEX ASSAYS FOR FELINE CYTOKINES, HORMONES & ADIPOKINES.
ID-1 PRELIMINARY FINDINGS ON USE OF SPIKE GENE MUTATIONS FOR DIAGNOSIS OF FELINE INFECTIOUS PERITONITIS (FIP).
ID-2 ADVANTAGES AND LIMITATIONS OF SEROLOGICAL AND MOLECULAR PANELS FOR THE DIAGNOSIS OF VECTOR-BORNE INFECTIOUS DISEASES IN DOGS.
ID-3 BARTONELLA CLARRIDGEIAE TRANSMISSION AMONG CATS EXPOSED TO CTENOCEPHALIDES FELIS.
ID-4 INFLUENCE OF CLINICAL AND LABORATORY VARIABLES ON FECAL ANTIGEN ELISA RESULTS IN DOGS WITH PARVOVIROSIS.
ID-5 COCURRENT MYCOBACTERIUM ABSCESSES INFECTION AND MAMMARY ADENOCARCINOMA IN A CAT: IS THERE A CONNECTION?.
ID-6 EVALUATION OF AN OUTPATIENT PROTOCOL IN THE TREATMENT OF CANINE PARVOVIRAL GASTROENTERITIS.
ID-7 VIDEO OBSERVATION OF INFECTION CONTROL PRACTICES DURING ROUTINE APPOINTMENTS IN COMPANION ANIMAL VETERINARY CLINICS IN ONTARIO, CANADA.
ID-8 HISTOPATHOLOGICAL CHANGES IN THE SKIN ASSOCIATED WITH PERSISTENT CANINE GRANULOCYTIC ANAPLASMOSIS.
ID-9 SURVEILLANCE FOR TICK-BORNE PATHOGENS IN MILITARY WORKING DOGS, SHELTER ANIMALS AND PET POPULATIONS IN COLOMBIA.
ID-10 EVALUATION FOR ASSOCIATIONS AMONG COXIELLA BURNETII AND REPRODUCTIVE ABNORMALITIES IN CATS.
ID-11 CANINE LEPTOSPIROSIS - A STATISTICAL EVALUATION OF SEROVARS PREDOMINANTLY INDUCING LEPTOSPIRAL ANTIBODY RESPONSES IN 3907 DOGS.
ID-12 URINE SEDIMENT IDENTIFICATION OF BLASTOMYCES DERMATITIDIS ORGANISMS IN DOGS WITH CONFIRMED SYSTEMIC INFECTION.
ID-13 TRENDS IN TICK-BORNE DISEASE EXPOSURE IN DOGS FROM THE USA AND CANADA DETERMINED BY SPECIES-SPECIFIC PEPTIDE ASSAY.
ID-14 SELF-REPORTED HAND HYGIENE AND GLOVE USE HABITS OF PRACTICING VETERINARIANS.
ID-15 ALPHA-1-ACID GLYCOPROTEIN CONCENTRATIONS IN CATS WITH FELINE INFECTIOUS PERITONITIS.
ID-16 VACCINE-ASSOCIATED LEPTOSPIRA ANTIBODY RESPONSES IN CLIENT-OWNED DOGS AFTER A ONE YEAR BOOSTER.
ID-17 ADMINISTRATION OF SQ AND INTRANASAL FHV-1 CONTAINING VACCINES CONCURRENTLY IS SUPERIOR TO USE OF A SQ VACCINE ALONE IN A ONE WEEK FHV-1 CHALLENGE MODEL.
ID-18 SELF-REPORTED HAND HYGIENE PRACTICES AND PERCEPTIONS IN COMPANION ANIMAL VETERINARY CLINICS IN ONTARIO, CANADA.
ID-19 CLINICAL TRIAL TO ASSESS THE EFFICACY OF PONAZURIL FOR THE TREATMENT OF COCCIDIOSIS IN DOGS AND CATS.
ID-20 EVALUATION FOR ASSOCIATIONS BETWEEN BARTONELLA SPECIES ANTIBODIES AND AZOTEMIA IN CLIENT-OWNED CATS.
ID-21 LEPTOSPIRA INTERROGANS SEROVAR HARDJO-PRAJITNO DNA IN THE URINE OF A CAT IN COLORADO.
ID-22 INDUCTION OF PROTECTIVE ANTIBODY TITERS IN SHELTER DOGS AFTER ADMINISTRATION OF A VACCINE CONTAINING RECOMBINANT CANINE DISTEMPER VIRUS AND MODIFIED-LIVE CANINE PARVOVIRUS.
ID-23 SERUM ELECTROLYTE ABNORMALITIES IN COMPLICATED CANINE BABESIOSIS.
ID-24 COMPARISON OF PREVALENCE OF FELINE LEUKEMIA AND IMMUNODEFICIENCY VIRUSES IN FERAL CATS ON THE SAN FRANCISCO PENINSULA, 2001-2003 AND 2005-2007.
ID-25 CORRELATION AMONG HISTOLOGICAL CHANGES AND THE PRESENCE OF CD3 + T AND CD79 + B LYMPHOCYTE WITH ANTIGENS OF LEISHMANIA INFANTUM IN RENAL TISSUE OF DOGS WITH VISCERAL LEISHMANIASIS.
ID-26 DETERMINATION OF BARTONELLA HENSELAE QUANTITATIVE PCR ASSAY RESULTS IN BLOOD SAMPLES OF FEBRILE AND AFEBRILE CLIENT-OWNED CATS.
ID-27 ACCURACY OF A POINT-OF-CARE IMMUNOASSAY TO DETERMINE PROTECTIVE ANTIBODY TITERS FOR CANINE PARVOVIRUS AND CANINE DISTEMPER VIRUS.
ID-28 TAIL VACCINATION IN CATS: BALANCING DISEASE PROTECTION AND CANCER TREATMENT.
ID-29 IN VITRO INTERACTION OF ATOVAQUONE AND PROGUANIL AGAINST BABESIA GIBSONI AND EFFICACY OF THE COMBINATION THERAPY FOR ACUTE CANINE BABESIOSIS.
ID-30 EVALUATION OF ANTIBODIES RESPONSE AGAINST LEPTOSPIRA INTERROGANS SEROVARS CANICOLA, ICTEROHAEMORRHAGIAE AND COPENHAGENI IN ADULT DOGS REVACCINATED ANNUALLY WITH COMMERCIAL VACCINE.
ID-31 EVIDENCE FOR FELINE IMMUNODEFICIENCY VIRUS, FELINE LEUKAEMIA VIRUS, BARTONELLA SPP, HAEMOPLASMAS , AND TOXOPLASMA SPP. EXPOSURE IN SINGAPOREAN CATS.
ID-32 PREVALENCE OF INFECTIOUS DISEASES IN LARGESCALE CAT HOARDING RESPONSES.
NU-1 THE EFFECT OF SAMPLE STORAGE MEDIA, REFRIGERATION, AND TIME ON URINE CULTURE ACCURACY IN CANINE URINE EXPERIMENTALLY INOCULATED WITH KNOWN BACTERIAL QUANTITIES.
NU-2 EVALUATION OF THE ACCUTEST URISCREEN FOR DETECTION OF BACTERIURIA AND PYURIA IN DOGS AND CATS.
NU-3 INCIDENCE AND PREVALENCE OF ASYMPTOMATIC BACTERIAL URINARY TRACT INFECTIONS IN HEALTHY, OLDER CATS.
NU-4 EVALUATION OF THE ASSOCIATION BETWEEN LEPTOSPIRE SPECIES ANTIBODIES AND AZOTEMIA IN CLIENT-OWNED CATS.
NU-5 COMPARISON OF URINE AND BLADDER OR URETHRAL MUCOSAL BIOPSY CULTURE OBTAINED BY TRANSURETHRAL CYSTOSCOPY, IN DOGS WITH CHRONIC LOWER URINARY TRACT DISEASE: 41 CASES (2002-2011).
NU-6 INTERVENTIONAL RENAL-SPARING TREATMENT OF OBSTRUCTIVE PYONEPHROSIS IN CANINE PATIENTS: 2008-2012.
NU-7 CIRCUMCAVAL URETERS IN TWENTY-ONE CATS.
NU-8 SERUM COBALAMIN, FOLATE, AND METHYLMALONIC ACID CONCENTRATIONS IN CATS WITH CHRONIC KIDNEY DISEASE.
NU-9 EVALUATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A BIOMARKER OF URINARY TRACT INFECTION IN NON-AZOTEMIC DOGS.
NU-10 CHANGES IN SYSTOLIC BLOOD PRESSURE OVER TIME IN CATS WITH CHRONIC KIDNEY DISEASE.
NU-11 CORRELATION OF SYMMETRIC DIMETHYLARGININE WITH GLOMERULAR FILTRATION RATE IN DOGS WITH CHRONIC PROGRESSIVE RENAL DISEASE.
NU-12 SEQUENTIAL STUDY OF URINARY PROTEINS BY SODIUM DODECYL SULPHATE POLYACRILAMIDE GEL ELECTROPHORESIS (SDS-PAGE) AND ALBUMIN-TOCREATININE RATIO IN DOGS WITH CHRONIC KIDNEY DISEASE.
NU-13 ATTENUATION OF THE PRESSOR RESPONSE TO EXOGENOUS ANGIOTENSIN BY ANGIOTENSIN RECEPTOR BLOCKERS IN NORMAL CATS.
NU-14 WEEK-TO-WEEK VARIABILITY OF IOHEXOL CLEARANCE, SERUM CREATININE, AND SYMMETRIC DIMETHYLARGININE IN DOGS WITH STABLE CHRONIC RENAL DISEASE.
NU-15 EVALUATION OF HEMOSTASIS IN 256 DOGS WITH RENAL DISEASE.
NU-16 INFLUENCE OF AZODYLTM ON UREA AND WATER METABOLISM IN UREMIC DOGS.
NU-17 VALIDATION OF A SLOW DIALYSATE BYPASS DEVICE (SDBD) PERMITTING SLOW HEMODIALYSIS DELIVERY ON INTERMITTENT HEMODIALYSIS PLATFORMS.
NU-18 MOLECULAR CHARACTERIZATION AND QUANTITATIVE PCR ANALYSIS OF FELINE GENE HOMOLOGUES ENCODING EICOSANOID BIOSYNTHETIC ENZYMES.
NU-19 SURVEY OF THE DIETARY AND MEDICATION PRACTICES OF OWNERS OF CATS WITH CHRONIC KIDNEY DISEASE.
NU-20 PREVALENCE OF VARIANT ALLELES ASSOCIATED WITH PROTEIN-LOSING NEPHROPATHY IN SOFT COATED WHEATEN TERRIERS.
NU-21 LCMS METHOD DEVELOPMENT AND VALIDATION FOR A POTENTIAL CHRONIC KIDNEY DISEASE MARKER SYMMETRICAL DIMETHYL ARGININE.
NU-22 COMPARISON OF PLASMA AND URINARY CLEARANCE OF EXOGENOUS CREATININE IN HEALTHY CATS.
NU-23 EVALUATION OF AN ESOPHAGO-JEJUNAL FEEDING TECHNIQUE IN DOGS WITH SEVERE ACUTE KIDNEY INJURY.
NU-24 SERUM AND URINE NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) CONCENTRATION IN HEALTHY DOGS AND DOGS WITH CHRONIC KIDNEY DISEASE.
NU-25 STABILITY OF SDMA (SYMMETRICAL DIMETHYL ARGININE) IN CANINE AND FELINE SERUM AND PLASMA.
NU-26 EFFICACY AND ADVERSE EFFECTS OF LANTHANUM CARBONATE IN CATS.
NU-27 ACUTE KIDNEY INJURY SECONDARY TO LILY INTOXICATION IN 30 CATS.
NU-28 ANALYTICAL VALIDATION OF THE PARTICLE-ENHANCED NEPHELOMETER FOR CYSTATIN C MEASUREMENT IN FELINE SERUM AND URINE.
NU-29 URINARY PH AFFECTS URINARY CALCIUM EXCRETION BUT NOT CALCIUM OXALATE RELATIVE SUPERSATURATION IN HEALTHY CATS.
NU-30 EFFICACY AND ADVERSE EFFECTS OF NITROFURANTOIN TREATMENT OF URINARY TRACT INFECTIONS IN DOGS AND CATS.
NU-31 PERCUTANEOUS FLUOROSCOPIC-ASSISTED PERINEAL APPROACH FOR RIGID CYTOSCOPY IN 9 MALE DOGS.
NU-32 DIAGNOSTIC ACCURACY OF A NOVEL POINT-OF-CARE URINARY CULTURE TEST IN DOGS.
NU-33 DEVELOPMENT OF FELINE CYSTATIN C ENZYME-LINKED IMMUNOSORBENT ASSAY KIT IN PLASMA AND URINE, AND ITS CLINICAL SIGNIFICANCE.
NU-34 LONG-TERM SAFETY OF ESTRIOL TABLETS IN HEALTHY BEAGLE DOGS.
NU-35 QUANTIFICATION OF SELECTED EICOSANOID METABOLITES IN URINARY BLADDERS OF HEALTHY CATS.
NU-36 UROTHELIAL EXPRESSION OF CYCLOOXYGENASES-1 (COX-1) AND 2 (COX-2), AND LIPOXYGENASE-5 (5-LOX) IN HEALTHY CATS AND CATS WITH LOWER URINARY TRACT DISEASES.
NU-37 CYSTOCENTESIS IN CATS: PROFESSIONAL PRACTICE EVALUATION.
NU-38 PREVALENCE AND CAUSES OF URINE SPECIFIC GRAVITY ≤ 1.035 IN APPARENTLY HEALTHY CATS PRESENTING TO FIRST OPINION PRACTICE.
NU-39 A DIAGNOSTIC TEST FOR FELINE IDIOPATHIC CYSTITIS BASED ON INFRARED MICROSPECTROSCOPY.
NU-40 INFLUENCE OF BLADDER FLUSHING ON DURATION OF CATHETERIZATION, HOSPITALIZATION AND RECURRENCE IN CATS WITH URETHRAL OBSTRUCTION.
NM-1 EFFECTS OF CHRONIC CALORIC RESTRICTION AND INTERMITTENT CALORIC RESTRICTION ON WEIGHT LOSS IN OVERWEIGHT CATS.
NM-2 CAN BODY COMPOSITION IN DOGS BE ESTIMATED FROM PHOTOGRAPHS?.
NM-3 INFLUENCE OF A NUTRACEUTICAL ON TREATMENT OF OBESITY IN RESEARCH BEAGLES.
NM-4 EFFECT OF A LOW-FAT DIET ON SERUM LIPOPROTEIN PROFILES IN MINIATURE SCHNAUZERS WITH PRIMARY HYPERLIPIDEMIA.
NM-5 MINERAL COMPOSITION OF WATER INDUCES CHANGES IN URINE OF CATS.
NM-6 LEAN BODY MASS INCREASES, BODY FAT DECREASES DURING WEIGHT MAINTENANCE FOLLOWING WEIGHT LOSS IN OBESE DOGS.
NM-7 LEAN BODY MASS INCREASES, BODY FAT DECREASES DURING WEIGHT MAINTENANCE FOLLOWING WEIGHT LOSS IN OBESE CATS.
NM-8 NUTRITIONAL STATUS OF DOGS UNDERGOING CALORIC RESTRICTION FOR WEIGHT LOSS FOR SELECTED NUTRIENTS.
NM-9 INCREASING DIETARY PROTEIN CONCENTRATION FROM 15% TO 30% IN A ONE YEAR STUDY INCREASES GLOMERULAR FILTRATION RATE AND REDUCES CREATININE AND SYMMETRICAL DI-METHYL ARGININE.
NM-10 FOODS WITH CONTROLLED PROTEIN AND PHOSPHORUS AND ENHANCED WITH ANTIOXIDANTS VITAMIN E AND C REDUCE CIRCULATING UREA AND SYMMETRICAL DI-METHYL ARGININE, AND INCREASE INOSINE IN DOGS.
OT-1 EFFECT OF MAROPITANT, ACEPROMAZINE AND ELECTROACUPUNCTURE IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH ADMINISTRATION OF MORPHINE IN DOGS.
OT-2 FORMULATION OF A PREDICTIVE MODEL TO CORRECT BLOOD GLUCOSE CONCENTRATIONS OBTAINED USING A VETERINARY POINT-OF-CARE GLUCOMETER IN ANEMIC AND HEMOCONCENTRATED CANINE SAMPLES.
OT-3 VIDEO OBSERVATION OF SHARPS HANDLING BEHAVIOURS IN COMPANION ANIMAL VETERINARY CLINICS IN ONTARIO, CANADA.
OT-4 MONITORING CLOUDY EYE PROGRESSION BY A LENS CLOUDINESS GRADING SCALE IN DOGS.
OT-5 SERUM C-REACTIVE PROTEIN CONCENTRATIONS IN DOGS WITH IDIOPATHIC EPILEPSY.
OT-6 A CLOSER MEDICAL LOOK AT CATS SHOWING INAPPROPRIATE URINATION: A CASE-CONTROL STUDY.
OT-7 EVALUATION OF THREE DIFFERENT POINT-OF-CARE TESTS FOR QUANTITATIVE DETECTION OF CANINE C-REACTIVE PROTEIN.
OT-8 AN ASSESSMENT OF ROUTINE WELLNESS BLOOD TESTING IN COMPANION DOGS.
OT-9 REPRODUCTIVE CAPACITY IS ASSOCIATED WITH LIFESPAN AND CAUSE OF DEATH IN COMPANION DOGS.
OT-10 DEMOGRAPHY OF SMALL ANIMAL CLINICAL CASES IN EGYPT.
OT-11 AN ASSESSMENT OF ROUTINE WELLNESS BLOOD TESTING IN COMPANION CATS.
OT-12 CANINES AND CHILDHOOD CANCER: EXAMINING THE EFFECTS OF ANIMAL-ASSISTED THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA, THEIR PRIMARY CAREGIVERS, AND THERAPY DOGS.
OT-13 POWER OF GENOME-WIDE ASSOCIATION STUDIES AND SEQUENCING FOR DISEASE AND TRAIT GENE DETECTION IN DOMESTIC CATS.
P-1 BIOEQUIVALENCE OF ITRACONAZOLE FORMULATIONS IN HEALTHY DOGS.
P-2 THE INFLUENCE OF CEFOVECIN ON THE ENANTIOSELECTIVE PHARMACOKINETICS OF CARPROFEN IN DOGS.
P-3 DEVELOPMENT OF DIABETES MELLITUS IN DOGS ADMINISTERED A COMBINATION OF CYCLOSPORINE AND PREDNISONE FOR IMMUNE-MEDIATED DISEASE.
P-4 HEMATOLOGICAL AND BIOCHEMICAL PROFILE OF CATS WITH ALIMENTARY LYMPHOMA AT TIME OF DIAGNOSIS.
P-5 ORAL, SUBCUTANEOUS AND INTRAVENOUS PHARMACOKINETICS OF ONDANSETRON IN HEALTHY CATS.
P-6 PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OF D-PENICILLAMINE IN FASTED AND NON-FASTED DOGS.
P-7 DETERMINATION OF SERUM SYMMETRIC DIMETHY-LARGININE REFERENCE LIMIT IN CLINICALLY HEALTHY DOGS.
P-8 A RANDOMISED CONTROLLED MASKED CLINICAL TRIAL OF A NOVEL NUTRACEUTICAL FOR TREATMENT OF OSTEOARTHRITIS IN THE DOG.
P-9 A METHOD FOR DETECTION AND QUANTITATION OF PLASMA LEVELS OF PIOGLITAZONE AFTER ORAL ADMINISTRATION IN DOGS.
P-10 EFFICACY OF IVERMECTIN INJECTION, CANAURAL EAR DROPS AND FRONTLINE COMBO IN TREATMENT OF EARMITE-INDUCED OTITIS EXTERNA IN CATS.
R-1 ASSESSMENT OF RESPIRATORY DYSFUNCTION IN DOGS WITH GOLDEN RETRIEVER MUSCULAR DYSTROPHY: ARTERIAL BLOOD GAS ANALYSIS AND TIDAL BREATHING SPIROMETRY.
R-2 EFFECT OF OBESITY ON PULMONARY FUNCTION IN CATS WITH NATURAL BRONCHIAL DISEASE.
R-3 ASSESSMENT OF AIRWAY HYPERRESPONSIVENESS IN TANDEM WITH REMODELING USING PULMONARY MECHANICS AND COMPUTED TOMOGRAPHY IN EXPERIMENTAL FELINE ASTHMA.
R-4 SHORT TERM USE OF MESENCHYMAL STEM CELLS FAILS TO MODULATE BGA-SPECIFIC AIRFLOW LIMITATION IN EXPERIMENTAL FELINE ASTHMA.
R-5 VALIDATION OF DIRECT AND INDIRECT BRONCHOPROVOCATION TESTING USING VENTILATOR-ACQURIED PULMONARY MECHANICS IN HEALTHY AND EXPERIMENTALLY ASTHMATIC CATS.
R-6 COMPARISON OF BRONCHOALVEOLAR LAVAGE ASPIRATION TECHNIQUES IN HEALTHY DOGS: HANDHELD SYRINGE AND SUCTION PUMP ASPIRATION.
R-7 EVALUATION OF MINIMALLY-INVASIVE MODEL OF AUTOLOGOUS BLOOD CLOT PULMONARY THROMBOEMBOLISM IN AN EXPERIMENTAL CANINE MODEL.
R-8 SEVERED ENDOTRACHEAL TUBE TRACHEAL FOREIGN BODIES IN DOGS AND CATS: 5 CASES.